Private equity and venture capital firms, emerging companies, and public and private companies turn to Chris for strategic, practical counsel regarding mergers and acquisitions, securities laws, venture capital, technology matters, and other corporate advice.
Chris is a partner in the Health Care & Life Sciences, Technology and Private Equity groups at Troutman Pepper.
He concentrates his practice in mergers and acquisitions, private equity, venture capital, and general corporate matters. His clients include private equity and venture capital firms, emerging companies, and public and private companies.
Chris represents domestic and foreign public and private companies and private equity funds in merger and acquisition transactions. He also represents private equity funds and emerging companies in venture capital, growth equity, and debt financing transactions. In addition, he counsels emerging companies in the life sciences, health care services, and technology industries in general corporate matters.
Representative matters may include engagements before joining Troutman Pepper.
Sponsored Events
10.29.24
2024 Mid-Atlantic Capital Conference – Presented by PACT
Sponsored Events
09.30.24
M&A East 2024
Sponsored Events
05.21.24
2024 Philadelphia Alliance for Capital and Technologies (PACT) Enterprise Awards
Firm News
02.28.24
Troutman Pepper Counsels Cagent Vascular in Series C Financing
Firm News
01.26.24
The M&A Advisor Recognizes Troutman Pepper with Three Turnaround Awards
Firm News
12.22.23
Troutman Pepper Advises Hidden River Strategic Capital in Investment in Diamond Blade Warehouse